These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2929441)

  • 1. Effect of dobutamine on plasma potassium in congestive heart failure secondary to idiopathic or ischemic cardiomyopathy.
    Goldenberg IF; Olivari MT; Levine TB; Cohn JN
    Am J Cardiol; 1989 Apr; 63(12):843-6. PubMed ID: 2929441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
    Biddle TL; Benotti JR; Creager MA; Faxon DP; Firth BG; Fitzpatrick PG; Konstam MA; Krebs C; Walton L; Kershner RP
    Am J Cardiol; 1987 Jun; 59(15):1345-50. PubMed ID: 3591689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Eichhorn EJ; Konstam MA; Weiland DS; Roberts DJ; Martin TT; Stransky NB; Salem DN
    Am J Cardiol; 1987 Dec; 60(16):1329-33. PubMed ID: 3687783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
    Marcus RH; Raw K; Patel J; Mitha A; Sareli P
    Am J Cardiol; 1990 Nov; 66(15):1107-12. PubMed ID: 2220638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
    Juillière Y; Feldmann L; Perrin O; Berder V; Danchin N; Cherrier F
    Int J Cardiol; 1995 Nov; 52(1):17-22. PubMed ID: 8707430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
    Likoff MJ; Ulrich S; Hakki A; Iskandrian AS
    Am J Cardiol; 1986 Jun; 57(15):1328-34. PubMed ID: 2940855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
    Durrieu C; Rochoux G; Coste P; Le Goff G; Besse P
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():43-50. PubMed ID: 2147834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsade de pointes ventricular tachycardia during low dose intermittent dobutamine treatment in a patient with dilated cardiomyopathy and congestive heart failure.
    Vecchia L; Ometto R; Finocchi G; Vincenzi M
    Pacing Clin Electrophysiol; 1999 Feb; 22(2):397-9. PubMed ID: 10087562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroadrenergic activation and response to dobutamine in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Vigna C; Fusilli S; Natali R; Russo A; De Rito V; Siena GP; Cianfrone N; Lombardo A; Fanelli R; Loperfido F
    Am J Cardiol; 2000 Aug; 86(4):422-6. PubMed ID: 10946036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion.
    Colucci WS; Leatherman GF; Ludmer PL; Gauthier DF
    Circ Res; 1987 Oct; 61(4 Pt 2):I82-6. PubMed ID: 3652407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of cardiac function in end-stage heart failure by combined use of dobutamine and amrinone.
    Guimond JG; Matuschak GM; Meyers F; Keating D
    Chest; 1986 Aug; 90(2):302-4. PubMed ID: 3731911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metoprolol on rest and exercise cardiac function and plasma catecholamines in chronic congestive heart failure secondary to ischemic or idiopathic cardiomyopathy.
    Nemanich JW; Veith RC; Abrass IB; Stratton JR
    Am J Cardiol; 1990 Oct; 66(10):843-8. PubMed ID: 2220583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
    Dubois-Randé JL; Comoy E; Merlet P; Benvenuti C; Carville C; Hittinger L; Macquin-Mavier I; Bohuon C; Castaigne A
    Eur Heart J; 1992 Sep; 13(9):1233-8. PubMed ID: 1396834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
    Colucci WS; Denniss AR; Leatherman GF; Quigg RJ; Ludmer PL; Marsh JD; Gauthier DF
    J Clin Invest; 1988 Apr; 81(4):1103-10. PubMed ID: 2832444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):391-8. PubMed ID: 1520649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
    Parodi O; Crea F; Pesola A; Distante A; Chierchia S; Moscarelli E; L'Abbate A; Maseri A
    G Ital Cardiol; 1980; 10(9):1141-7. PubMed ID: 7193152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure.
    Gibelin P; Sbirrazzuoli V; Drici M; Camous JP; Lapalus P; Morand P
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1105-11. PubMed ID: 1964577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.